HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- RFA-NS-23-007
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.213 Research and Training in Complementary and Integrative Health
- 93.233 National Center on Sleep Disorders Research
- 93.242 Mental Health Research Grants
- 93.273 Alcohol Research Programs
- 93.350 National Center for Advancing Translational Sciences
- 93.351 Research Infrastructure Programs
- 93.393 Cancer Cause and Prevention Research
- 93.395 Cancer Treatment Research
- 93.396 Cancer Biology Research
- 93.837 Cardiovascular Diseases Research
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Income Security and Social Services
- Eligible applicants
-
- Small Businesses
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity